Thankyou to our Headline Sponsors above
Contact Lenses

CooperVision launches MyDay® MiSight® 1 day: its latest Contact Lens for Myopia Control.

Posted on by

CooperVision launches MyDay® MiSight® 1 day: its latest Contact Lens for Myopia Control.


Innovation Combines Advanced Silicone Hydrogel Material with Proven ActivControl® Technology.*1

CooperVision today announced the launch of MyDay® MiSight® 1 day contact lenses, its latest innovation with ActivControl® Technology designed to slow the worsening of myopia in children.†2,3 The new product combines the advanced silicone hydrogel material of MyDay® lenses with the proven ActivControl® Technology found in original MiSight® 1 day lenses.*1

Elizabeth Lumb, Director, Global Professional Affairs, Myopia at CooperVision, explained the significance of the launch: “One in two children born today could have myopia by the age of 20,4 which can significantly impact their quality of life—making it harder to participate in school, sports and other activities.5,6 Myopia can worsen rapidly, especially in younger children, so early intervention is important.7

Our commitment to tackling myopia—both scientifically and commercially—has been unwavering. With MyDay® MiSight® 1 day, we’ve brought together the advanced silicone hydrogel material found in our MyDay® contact lenses with the life-changing potential of myopia control.*1”

The company’s ActivControl® Technology has been shown to cut the worsening of myopia by approximately 50% and is backed by the longest-running soft contact lens clinical trial among children.†‡2,3 More than 200,000 children globally now wear contact lenses featuring this technology.8 The lens design incorporates vision correction zones and treatment zones  to provide clear vision while helping to control the worsening of myopia.‡1,3,9

The new product offers better comfort and handling features compared with original MiSight® 1 day:§♢9

  • Preferred for comfort compared to the original MiSight® 1 day9
  • Up to four times the oxygen transmissibility of a hydrogel one-day lens
  • Built-in UV blocking**
  • Rated easier to apply compared to the original MiSight® 1 day.♢9

Chithra Dhanabalan, Professional Affairs Manager, UK&I at CooperVision, added: “This innovation delivers ‘always-on’ myopia control—children benefit from treatment throughout the day, simply by wearing their contact lenses.††3,9,10 It’s also designed to help support a smooth transition from myopia management to adult lens wear, thanks to its shared material and specifications with MyDay® lenses.‡‡”

To support eye care professionals, CooperVision offers a suite of business tools including OptiExpert™, the Axial Length Estimator and QuickStart e-learning accreditation—all available at no cost. In-practice marketing materials are also available on request. §§♢♢

MyDay® MiSight® 1 day will be available from 19th January 2026. Accredited customers can order both trial and revenue lenses through their usual CooperVision channels. At launch, the product will be available in the following parameters:

Sphere Power Range Step Size
-0.25 to -6.00 0.25D
-6.50 to -10.00 0.50D

 

To learn more about CooperVision’s evidence-based myopia management portfolio, visit: www.coopervision.co.uk or contact your CooperVision representative.

References

* Proven to slow myopia progression in children compared to a single vision 1-day lens over a 3-year period

†Using measured and modeled data, pooled across ages (8-17), myopia progression was slowed by an average of approximately 50% with MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day

‡ MyDay® MiSight® 1 day contact lenses use the same ActivControl® Technology as the original MiSight® 1 day

  • 19% vs. 3% after 1 week of daily wear, p=0.02

♢94% vs. 81% after 1 week of daily wear, p=NS

¶ Based on manufacturers published data. MyDay® MiSight® 1 day has Dk/t of 100. Compared to the original MiSight® 1 day (Dk/t 28), NaturalVue Multifocal 1 Day (Dk/t 25)

** Warning: UV-absorbing contact lenses are not substitutes for protective UV-absorbing eyewear, such as UV-absorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. Patients should continue to use UV-absorbing eyewear as directed

†† In clinical study, mean weekday wear time increased from 12.8 hours/day at 6-months to 13.9 hours/day at 6-years with a mean of >6.5 days/week for MiSight® 1 day, which shares the same ActivControl® Technology with MyDay® MiSight® 1 day

‡‡ MyDay® daily disposable and MyDay Energys®

  • § OptiExpert™ is an educational, reference and information tool for eye care professionals who may choose to use the app in connection with their own patient evaluation but it is not intended to be relied upon for clinical decision-making. OptiExpert™ is not intended as and does not constitute medical or optometric advice, nor is it intended to replace the patient evaluation performed by an eye care professional.

♢♢ Information on market promotions can be requested from your CooperVision Business Partner

  1. Chamberlain P et al A 3-year Randomised Clinical Trial of MiSight Lenses for Myopia Control. OVS 2019;96:556-567.
  2. Arumugam B et al. Modelling Age Effects of Myopia Progression for the MiSight 1 day Clinical Trial. IOVS 2021;62(8):2333
  3. CVI data on file, 2025
  4. Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042
  5. Lamoureux E et al. Myopia and Quality of Life: The Singapore Malay Eye Study (SiMES). IOVS 2008;49(13):4469
  6. Chua S.Y.L., Foster P.J. (2020) The Economic and Societal Impact of Myopia and High Myopia:53-63. In: Ang M., Wong T. (eds) Updates on Myopia. Springer, Singapore
  7. Zadnik K. et al. Factors Associated with Rapid Myopia Progression in School-aged Children. IOVS 2004;45(13):2306.
  8. CVI data on file, 2025. Internal MiSight® 1 day global wearer modeling estimates for the 12-month period of June 2024 to May 2025
  9. CVI data on file, 2025. Prospective, 1-week, double masked, bilateral study with MiSight 1 day silicone hydrogel. N=32 subjects aged 8-18 years
  10. Woods J et al. Ocular health of children wearing daily disposable contact lenses over a 6-year period. CLAE 2021 Aug;44(4):101391